Clinical Trial Update: Evaluating the Safety and effectivenesS in Adult KorEaN Patients Treated With Tolvaptan for Management of Autosomal domInAnt poLycystic Kidney Disease [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating safety and effectiveness of tolvaptan in adult Korean patients with autosomal dominant polycystic kidney disease has completed…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autosomal Dominant Polycystic Kidney Disease

Drugs mentioned

• tolvaptan (tolvaptan)

Snippet

Sponsor: Korea Otsuka Pharmaceutical Co., Ltd. | Conditions: Autosomal Dominant Polycystic Kidney Disease (ADPKD) | Phase 4 | Status: COMPLETED